Objectives. Chronic pain management typically consists of prescription medications or providerbased, behavioral, or interventional procedures that are often ineffective, may be costly, and can be associated with undesirable side effects. Because chronic pain affects the whole person (body, mind, and spirit), patient-centered complementary and integrative medicine (CIM) therapies that acknowledge the patients' roles in their own healing processes have the potential to provide more efficient and comprehensive chronic pain management.
Introduction
Chronic pain is a common problem today that presents considerable challenges to the health care system because of its complex etiology and poor responses to current treatment strategies. Conventional pain management methods have been largely dependent on the use of prescription and over-the-counter medication and opioids, which often lead to a myriad of other problems (e.g., drug dependence, adverse events) and are found, in many instances, to be ineffective for the management of chronic pain symptoms. There have been promising results in the area of integrative health care approaches, which may provide more efficient and comprehensive pain management through a collaborative approach and shared health care vision that permits both practitioner and patient to contribute to a shared and synergistically charged plan of care [1] . In fact, in 2002 as well as 2007, the National Health Interview Survey, an annual in-person survey of Americans regarding their healthand illness-related experiences, reported that individuals with chronic pain, particularly back, neck, and joint pain, commonly sought more integrative approaches to care [2] . Potential explanations for this growth in complementary and integrative medicine (CIM) use include dissatisfaction with conventional medicine and the desire of patients to be actively involved with medical decision making [3] .
Integrative health care approaches typically involve conventional medicine as well as active self-care (ACT) CIM therapies that acknowledge the patient's role in their own healing. The authors consider ACT-CIM to be integrative in nature and define them as therapies that 1) incorporate complementary medicine with conventional medicine as a collaborative and integral part of health care; and 2) can be performed by individuals on their own after they have become fully trained in the therapy. To date, there have been no systematic reviews examining the full range of ACT-CIM used for chronic pain management. As such, a systematic review was conducted to evaluate the evidence base for these therapies. The authors detail the entire scope of the review throughout the Pain Medicine supplement and describe the efficacy of the following five broad categories of modalities identified through the review, as classified by the authors: mind-body therapies [4] , movement therapies [5] , physically oriented therapies [6] , sensory art therapies [7] , as well as multimodal integrative approaches [8] .
In this review, the authors define efficacy as "the extent to which a specific intervention is beneficial under ideal conditions." [9] Such trials [4] [5] [6] [7] [8] typically focus on the causal effects of a treatment (i.e., ACT-CIM modality) by comparing it to a placebo, or in this case, a non-ACT-CIM therapy. In contrast, the authors define effectiveness as a "measure of the extent to which a specific intervention, when deployed in the field in routine circumstances, does what it is intended to do for a specific population." Comparative effectiveness trials typically compare interventions to similar interventions or usual care [9] . This type of research is designed to inform health care decisions by providing evidence on the effectiveness, benefits, and harms of different treatment options and help individuals, providers, and clinicians decide which treatment option is the "best choice," based on the direct comparisons made between identified treatment arms studied. As such, this article focuses on determining the effectiveness of various ACT-CIM therapies and describes studies that met the review's inclusion criteria and directly compared two ACT-CIM therapies (e.g., self-hypnosis vs autogenic training) with each other; studies comparing an ACT-CIM therapy to a non-ACT-CIM therapy are described in other chapters within this supplement [4] [5] [6] [7] . The authors hope these analyses will illuminate differences and nuances between such modalities and how they each affect different populations and conditions. This information can then enable researchers to determine whether it is reasonable and appropriate, given the existing literature to date, to begin moving away from standard randomized controlled trial (RCT) study designs that test efficacy and toward more comparative effectiveness research models.
Methods
A systematic review was conducted, using Samueli Institute's Rapid Evidence Assessment of the Literature methodology, to comprehensively and rigorously assess both the quality of the research on active self-care complementary and integrative therapies and the evidence for their effectiveness in treating chronic pain symptoms. All articles meeting the review's predefined inclusion criteria were assessed for methodological bias and quality using the Scottish Intercollegiate Guidelines Network (SIGN) 50 Checklist [10] Although a group of subject matter experts (SMEs; N = 9) were assembled to assess the overall literature pool of each ACT-CIM modality in pairs using the Grading of Recommendations, Assessment, Development and Evaluation Methodology [11] , this process was not applied to this subset of studies as they were too heterogeneous to evaluate as a whole. Instead, all SMEs were convened as a working group at a 1-day meeting during which they developed recommendations for the use and implementation of included single modalities, summarized and discussed the evidence for these multimodal integrative therapies, and outlined next steps for moving this research field forward. The review's full methodology is detailed in another article within this supplement [12] .
Study Selection
A total of 2,771 articles were yielded from the database searches. Of the 146 articles that met the systematic review's inclusion criteria, 18 RCTs directly compared one ACT-CIM therapy to another ACT-CIM therapy (see Figure 1 for flow chart).
Overall Quality Assessment
Based on SIGN 50 criteria used to assess methodological bias and quality, the majority (N = 13) of studies that compared one ACT-CIM therapy to at least one other ACT-CIM therapy were poor quality (−). Only five studies [13] [14] [15] [16] [17] were high quality (+). Most studies addressed an appropriate and clearly focused question, dropout rates, baseline similarities between treatment groups, and outcome reliability and validity either adequately or well. Criteria surrounding randomization, allocation concealment, and intention-to-treat analyses, however, were poorly addressed, indicating failure on the part of the authors of
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Results
The majority of these effectiveness studies compared relaxation, guided imagery/self-hypnosis, biofeedback, and autogenic training modalities with one another. Relaxation and autogenic training were found to be equally effective [18] . No significant differences were found between relaxation and journaling/storytelling [13] ; however, relaxation was cited as being as effective as therapeutic touch [19] . Further, compared with one another, relaxation and guided imagery/self-hypnosis were generally found to be equally effective [15, 20, 21] , with the 
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exception of two studies reporting guided imagery/selfhypnosis as more effective [22, 23] and another reporting neither to be effective [17] . Guided imagery, moreover, was also found to be as effective as both autogenic training [16] and biofeedback [14] . In a study comparing biofeedback with transcutaneous electrical nerve stimulation (TENS), biofeedback was reportedly more effective than TENS [24] . Contrastingly, evidence regarding relaxation and biofeedback were fairly mixed; in some studies, relaxation was reported to be either as effective [25] or more effective [25, 26] than biofeedback, depending on the study time point, while a similar amount of studies demonstrated biofeedback to be more effective than relaxation [27] [28] [29] . Lastly, when comparing variations of types of modalities with one another (e.g., type of biofeedback vs another type of biofeedback), results show that while these can be comparable [30] , one is often more effective than the other [20, 27] (see Table 2 for full description of all studies).
In Table 3 , the authors display the total number of studies for each category (i.e., relaxation vs guided imagery/selfhypnosis) as well as the number of high-and poor-quality studies. Results of the high-quality results are then detailed to show where there is good evidence comparing various ACT-CIM therapies with one another. Interestingly, for this subset of studies, results among the high-quality studies were consistent, with both modalities either being equally effective or not effective at all.
Discussion
The literature included in this review provided direct comparisons between identified ACT-CIM therapies and were quite mixed in terms of effectiveness results. Overall, the majority of ACT-CIM therapies were focused on improving patient coping skills for chronic pain (e.g., relaxation techniques, emotional disclosure). Relaxation training, but not written emotional disclosure, showed potential to decrease pain in college students with migraine and tension headaches [13] in an inadequately controlled phase II-like RCT. Autogenic training and cognitive self-hypnosis showed potential to decrease pain symptoms in patients with chronic headache in a phase II-like inadequately controlled RCT that is almost 20 years old [16] . Analgesic imagery, and to a lesser extent, progressive muscle relaxation (PMR) showed potential to decrease in-patient cancer pain symptoms [15] in a very small phase II-like crossover design RCT. Self-hypnosis training, and to a lesser extent, electromyograph biofeedback showed potential to decrease pain symptoms in spinal cord injury patients [15] in a very small phase II-like RCT without control. Guided imagery with PMR showed potential to improve symptoms in children with chronic abdominal pain [17] in an inadequately controlled, small RCT. As such, although the RCTs on ACT-CIM modalities included in this review demonstrate potential for efficacy, effectiveness, and safety, planning and implementation of high-quality study designs are needed to truly elucidate the effectiveness of these modalities.
While the literature base is fully described in this current article, the authors recommend exercising caution when interpreting these data, as they believe this literature is still in its infancy; more research (i.e., conduction of "gold standard" RCTs in comparison with wait list, placebo, usual care, or standard care models) needs to be conducted to fully understand which modalities are efficacious before comparing them with one another (i.e., conducting comparative effectiveness research). Because there are gaps in the methodology (e.g., how modalities are studied and reported) utilized in the individual studies [4] [5] [6] [7] [8] , this literature base is still questionable in terms of simply identifying either efficacious or effective modalities. Until efficacy is well understood, researchers should continue to question why effectiveness, rather than efficacy, studies continue to be funded.
In order to produce scientifically reliable results regarding efficacy and effectiveness, ACT-CIM investigators should, whenever possible, emulate established "biological model" drug approval processes and aim to establish reliable [31] , focused, biologically plausible, and controlled (to the extent possible, using sham and other "placebo" modalities) data to answer focused questions. As such, investigators should pursue rational and deliberate clinical development plans for individual self-care modalities starting with small (N ∼ 20-80) phase I-like RCTs in healthy volunteers to rule out common adverse events, followed by moderate-sized (N ∼ 80-300) phase II-like RCTs in relatively homogeneous populations of patients with chronic pain to assess efficacy preliminarily (hypothesis generation), followed by larger (N ∼ 300-3,000) phase III-like RCTs in more clinically relevant heterogeneous populations of patients with chronic pain to more definitively confirm efficacy, detect less frequent adverse events, and optimize "dosing." For some ACT-CIM modalities that are highly unlikely to cause harm, investigators might start with phase II-like studies. Subsequent to completion of a definitive phase III RCT in which a robust database will have been garnered in at least one indication, similar phase II-and phase III-like studies should be done in other indications and compared against, or in combination with, other modalities. Finally, the authors believe that objective correlations to confirm subjective behavioral outcome end points (i.e., objective physiologic correlates of pain), as well as to add biologic plausibility, should be included in trial designs where possible (e.g., functional magnetic resonance imaging, biomarkers).
The authors realize this is a difficult request to the field, considering the complex nature of chronic pain and the challenges of incorporating integrative medicine approaches into our current health care system model. The reductionist science model, as described above, is well matched for pharmaceutically based biomedicine; however, it does not always fit the holistic and multidimensional whole-person view (i.e., physical, emotional, social) espoused by CIM therapies. The authors herein believe that rational clinical development pathways (i.e., progressing through phases I, II, and III trials) are required for investigations of ACT-CIM
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Table 3
Summary of results from high-quality studies comparing active self-care complementary and integrative medicine (ACT-CIM) therapies * Neither: neither integrative approach nor control(s) is significant; both: both integrative approach and control(s) are equally effective.
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Conclusion
This review of the literature regarding active self-care modalities for treatment of chronic pain shows that although a number of trials have been conducted and published, few are of high quality and still fewer provide robust answers to clinical questions about efficacy, effectiveness, and safety. Encouraging efficacy results yielded from even the higher quality trials, which were somewhat akin to phase I-II drug trials, are hypothesis generating at best, due to small size, inadequate control and blinding, bias, as well as other confounding issues prevalent throughout the studies included in this review.
Other than suggesting that self-care modalities are likely generally safe, the literature is too preliminary to provide any guidance to clinicians regarding efficacy or effectiveness; the authors believe that ethical full disclosure requires health care providers prescribing or recommending self-care modalities for chronic pain to inform their patients about the state of the literature. Moreover, investigators should concentrate on efficacy studies for singular modalities in focused indications before extending to combinational and/or comparative effectiveness research.
